A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria

Investigational site, Blagoevgrad

Investigational site, Burgas

Investigational site, Byala

Investigational site, Golenci

Investigational site, Pazardzhik

Investigational site, Plovdiv

Investigational site, Rousse

Investigational site, Sofia

Investigational site, Varna

Investigational site, Baja

Investigational site, Budapest

Investigational site, Debrecen

Investigational site, Eger

Investigational site, Kistelek

Investigational site, Komárom

Investigational site, Pécs

Investigational site, Szigetvár

Investigational site, Szikszó

Investigational site, Zalaegerszeg

Investigational site, Kaunas

Investigational site, Klaipėda

Investigational site, Vilnius

Investigational site, Bacau

Investigational site, Baia Mare

Investigational site, Brasov

Investigational site, Brăila

Investigational site, Bucharest

Investigational site, Cluj-Napoca

Investigational site, Iași

Investigational site, Oradea

Investigational site, Ploieşti

Investigational site, Satu Mare

Investigational site, Târgu Mureş

Investigational site, Timișoara

Investigational site, Banská Bystrica

Investigational site, Bardejov

Investigational site, Bratislava

Investigational site, Lučenec

Investigational site, Martin

Investigational site, Nitra

Investigational site, Šahy

Investigational site, Štúrovo

Investigational site, Žilina